These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 15371902)

  • 1. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.
    Watson MS; Cutting GR; Desnick RJ; Driscoll DA; Klinger K; Mennuti M; Palomaki GE; Popovich BW; Pratt VM; Rohlfs EM; Strom CM; Richards CS; Witt DR; Grody WW
    Genet Med; 2004; 6(5):387-91. PubMed ID: 15371902
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystic fibrosis carrier screening in a North American population.
    Zvereff VV; Faruki H; Edwards M; Friedman KJ
    Genet Med; 2014 Jul; 16(7):539-46. PubMed ID: 24357848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier screening, incidence of cystic fibrosis, and difficult decisions.
    Liou TG; Rubenstein RC
    JAMA; 2009 Dec; 302(23):2595-6. PubMed ID: 20009063
    [No Abstract]   [Full Text] [Related]  

  • 4. Cystic fibrosis carrier screening: issues in implementation.
    Watson MS; Desnick RJ; Grody WW; Mennuti MT; Popovich BW; Richards CS
    Genet Med; 2002; 4(6):407-9. PubMed ID: 12509709
    [No Abstract]   [Full Text] [Related]  

  • 5. The expanding phenotype of cystic fibrosis.
    Smith JM; Kirk EP
    Med J Aust; 2004 Nov; 181(9):514. PubMed ID: 15516201
    [No Abstract]   [Full Text] [Related]  

  • 6. ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.
    Obstet Gynecol; 2011 Apr; 117(4):1028-1031. PubMed ID: 21422883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis.
    Strom CM; Crossley B; Buller-Buerkle A; Jarvis M; Quan F; Peng M; Muralidharan K; Pratt V; Redman JB; Sun W
    Genet Med; 2011 Feb; 13(2):166-72. PubMed ID: 21068670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
    Bobadilla JL; Farrell MH; Farrell PM
    Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
    [No Abstract]   [Full Text] [Related]  

  • 9. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to molecular cystic fibrosis testing.
    Uphoff TS; Highsmith WE
    Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CF gene: 10 years on.
    Geddes DM; Alton EW
    Thorax; 1999 Dec; 54(12):1052-4. PubMed ID: 10567621
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutation distribution in expanded screening for cystic fibrosis: making up the balance in a context of ethnic diversity.
    Schrijver I
    Clin Chem; 2011 Jun; 57(6):799-801. PubMed ID: 21474640
    [No Abstract]   [Full Text] [Related]  

  • 13. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current challenges in cystic fibrosis screening.
    Lyon E; Miller C
    Arch Pathol Lab Med; 2003 Sep; 127(9):1133-9. PubMed ID: 12946232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for cystic fibrosis: an early report card.
    Palomaki GE
    Genet Med; 2004; 6(3):115-6. PubMed ID: 15354327
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X.
    Grody WW
    Genet Med; 2011 Dec; 13(12):996-7. PubMed ID: 22134443
    [No Abstract]   [Full Text] [Related]  

  • 17. New cystic fibrosis genetic tests bring hope and dilemmas.
    Arnold C
    Lancet Respir Med; 2014 Jan; 2(1):30. PubMed ID: 24461897
    [No Abstract]   [Full Text] [Related]  

  • 18. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnostic Next-Generation sequencing: the case of CFTR carrier screening.
    Loukas YL; Thodi G; Molou E; Georgiou V; Dotsikas Y; Schulpis KH
    Scand J Clin Lab Invest; 2015 Sep; 75(5):374-81. PubMed ID: 25874479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.